Pfizer Limited (PFIZER) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Pfizer Limited stock ₹3,352, price ₹3,818, that is 12.2% below the price, quality 82 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Pfizer Limited
PFIZER · NSEExpensive (fair value 12% below the price) and falling price, but strong company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹3,240 – ₹6,042 · fair‑value band ₹2,606 – ₹4,089 · the ₹3,818 price screens above the ₹3,352 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Pfizer is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
Show moreShow less
It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients.
The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Stock analysis
Pfizer Limited (PFIZER) currently trades at ₹3,818, while our model-based Fair Value estimate is ₹3,352, 12% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹3,453 per share, and 1 of the 26 models we run sit above the ₹3,818 price.
Bear case: the Asset-Based group reads lowest at ₹674.18, and 25 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹2,606 (bear) to ₹4,089 (bull), the price of ₹3,818 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 82/100 (high quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Pfizer Limited reported revenue of ₹25.2B in FY2026 versus ₹26.1B in FY2022, a compound −0.9%/yr. Reported net income was ₹7.2B in FY2026, compounding +4.2%/yr from FY2022.
Key figures
Market cap ₹175B (≈ $1.9B) Small · P/E ratio 22.9 · P/S ratio 6.63 · EPS (TTM) ₹166.49 · Dividend yield 2.0% · Net margin 32.4% · Return on equity 20.9% · Return on assets (EBIT) 24.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 86 out of 100 (low confidence).
What moves the price
The share trades about 25% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −12%, PFIZER screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
PFIZER screens overvalued: fair value 12% below the price. Compare with Eli Lilly and Company →
Compare Pfizer Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 73 stocks
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Bristol-Myers Squibb Company BMY | $63.43 | $75.91 | +20% | vs PFIZER |
| Amgen Inc AMGN | $465.67 | $512.24 | +10% | vs PFIZER |
| Gilead Sciences, Inc GILD | $168.08 | $184.89 | +10% | vs PFIZER |
| Novartis AG NOVN | CHF 134.06 | CHF 122.91 | −8% | vs PFIZER |
| AbbVie Inc ABBV | $295.03 | $259.62 | −12% | vs PFIZER |
| Merck & Co MRK | $147.76 | $129.26 | −13% | vs PFIZER |
| Pfizer Inc PFE | $28.89 | $24.87 | −14% | vs PFIZER |
| Roche Holding RO | CHF 412.00 | CHF 326.56 | −21% | vs PFIZER |
| Johnson & Johnson, JNJ | $285.75 | $169.03 | −41% | vs PFIZER |
| Eli Lilly and Company LLY | $1,444 | $749.92 | −48% | vs PFIZER |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Pfizer Limited (PFIZER) overvalued or undervalued?
What is the fair value of PFIZER?
What is the quality score of PFIZER?
What is the price target for Pfizer Limited (PFIZER)?
What is the Pfizer Limited stock forecast for 2026?
What is the revenue of Pfizer Limited (PFIZER)?
Does Pfizer Limited pay a dividend?
How much is the dividend of Pfizer Limited (PFIZER) and when is the ex-dividend date?
What growth is priced into Pfizer Limited (PFIZER)?
What discount rate (WACC) does the fair value of PFIZER use?
What is a reverse DCF?
How much growth has Pfizer Limited (PFIZER) delivered so far?
How fast is the sector of Pfizer Limited (PFIZER) growing?
What is the free cash flow yield of Pfizer Limited (PFIZER)?
What is the intrinsic value of Pfizer Limited (PFIZER)?
Is Pfizer Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of PFIZER?
How much is Pfizer Limited worth?
What do the bullish and bearish scenarios say about PFIZER?
What is the P/E ratio of PFIZER?
How solid is the balance sheet of Pfizer Limited (PFIZER)?
How far is PFIZER from its 52-week high?
Which stocks are comparable to Pfizer Limited?
Is Pfizer Limited stock attractive at the current price?
How is the fair value of PFIZER calculated?
Is it still worth investing in stocks now?
What is the share price of Pfizer Limited (PFIZER)?
What should I pay attention to with Pfizer Limited right now?
Where does the earnings growth of Pfizer Limited (PFIZER) come from?
Key figures of Pfizer Limited
How large is the market capitalisation of Pfizer Limited (PFIZER)?
What is the P/S ratio of Pfizer Limited (PFIZER)?
What are the earnings per share of Pfizer Limited (PFIZER)?
What is the dividend yield of Pfizer Limited (PFIZER)?
What is the net margin of Pfizer Limited (PFIZER)?
What is the return on equity of Pfizer Limited (PFIZER)?
What is the EBIT return on assets of Pfizer Limited (PFIZER)?
What is the operating margin of Pfizer Limited (PFIZER)?
How fast is revenue growing at Pfizer Limited (PFIZER)?
How fast are earnings growing at Pfizer Limited (PFIZER)?
How much net cash does Pfizer Limited (PFIZER) hold?
Watch Pfizer Limited in the live analysis
One click puts Pfizer Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.